| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |